top of page
Blue and Green Illustrative Healthcare Process Infographic (5).jpg

Named Patient Program – Secure Orphan Drug Access from EU, USA & Canada

At RIVERPHARMA, we support patients and healthcare providers in accessing orphan drugs and essential medicines that are not yet available in their country. Through our Named Patient Program, we facilitate a compliant and secure supply of hard-to-find treatments, sourced exclusively from the EU, USA, and Canada.
 

This service is exclusively managed by orphandrug.co.uk, A RiverPharma Initiative, ensuring patients receive genuine, high-quality orphan drugs from GDP-certified suppliers across these regions.

How Our Named Patient Program Works?

Request Your Medicine

  • If an orphan drug or essential medicine is unavailable in your country, contact us. Our team will source it through our trusted suppliers in EU, USA, and Canada.

Provide Required Documents

  • Upload your prescription and necessary paperwork. Our team will guide you through the regulatory requirements.

Receive Pricing & Confirm Order

  • We provide a detailed quotation, including medicine cost, logistics, and compliance details. Once confirmed, the order is processed.

Secure & Fast Shipping

  • The medicine is sourced exclusively from GDP-certified suppliers in the EU, USA, and Canada and shipped via trusted logistics partners, ensuring safe and timely delivery.

Receive Your Medicine

  • Your order arrives at your location. We provide tracking and ongoing support to ensure a smooth process.

A RiverPharma Initiative dedicated to providing reliable Named Patient access for orphan drugs from EU, USA, and Canada. Let us help you obtain the life-saving medicines you need, wherever you are.

Riverpharma Ltd
🌍 Sourcing from EU, USA & Canada | Serving 86+ Countries

 

Company Registration Number: 12959904
60+ GDP-Certified Suppliers | Trusted by 200+ Healthcare Professionals
📍UK | Serving 86+ Countries

Wide Range of Orphan & Specialty Medicines
📧 info@river-pharma.co.uk | +44 (0) 7435 574968 
© 2025 Riverpharma Ltd | All Rights Reserved

  • LinkedIn
bottom of page